Hamlet Pharma AB   Report issue

For profit Phase 2
Founded: Lund Sweden (1999)

Organization Overview

First Clinical Trial
2018
NCT03560479
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hamlet Pharma AB